Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.12
-0.17 (-1.28%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Avanos Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -72.9 | -392.1 | -61.8 | 50.5 | 6.3 | Upgrade
|
| Depreciation & Amortization | 38.9 | 45.5 | 43.5 | 41.2 | 38.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | 9.3 | 1.2 | 1.9 | 1.1 | 8 | Upgrade
|
| Asset Writedown & Restructuring Costs | 77 | 436.7 | - | - | - | Upgrade
|
| Stock-Based Compensation | 12.6 | 13.8 | 15.8 | 15.9 | 13.2 | Upgrade
|
| Other Operating Activities | -10.4 | -39.4 | -22.4 | - | -3 | Upgrade
|
| Change in Accounts Receivable | 30.9 | -6.6 | 39 | -24.7 | -10.8 | Upgrade
|
| Change in Inventory | 0.2 | 39 | 4.7 | -30.9 | 15.7 | Upgrade
|
| Change in Accounts Payable | 0.6 | -0.9 | -14.4 | 35.4 | -11.9 | Upgrade
|
| Change in Other Net Operating Assets | -11.5 | 3.5 | -47.3 | -4.1 | 31.5 | Upgrade
|
| Operating Cash Flow | 74.7 | 100.7 | 32.4 | 90.9 | 87.3 | Upgrade
|
| Operating Cash Flow Growth | -25.82% | 210.80% | -64.36% | 4.12% | - | Upgrade
|
| Capital Expenditures | -31.6 | -17.8 | -17.8 | -19.3 | -21 | Upgrade
|
| Sale of Property, Plant & Equipment | 4 | - | - | - | - | Upgrade
|
| Cash Acquisitions | -28 | - | -49.6 | -116.1 | - | Upgrade
|
| Divestitures | - | - | 89 | - | - | Upgrade
|
| Investment in Securities | -5 | -11.8 | - | - | - | Upgrade
|
| Other Investing Activities | - | 2.1 | - | - | - | Upgrade
|
| Investing Cash Flow | -60.6 | -27.5 | 21.6 | -135.4 | -21 | Upgrade
|
| Long-Term Debt Issued | - | 20 | 55 | 400 | 20 | Upgrade
|
| Total Debt Issued | - | 20 | 55 | 400 | 20 | Upgrade
|
| Long-Term Debt Repaid | -34.4 | -53.6 | -119.7 | -296.6 | -70 | Upgrade
|
| Total Debt Repaid | -34.4 | -53.6 | -119.7 | -296.6 | -70 | Upgrade
|
| Net Debt Issued (Repaid) | -34.4 | -33.6 | -64.7 | 103.4 | -50 | Upgrade
|
| Issuance of Common Stock | 0.7 | 1.1 | 1.3 | 1.7 | 6.2 | Upgrade
|
| Repurchase of Common Stock | -3.3 | -12.8 | -19.1 | -45.5 | -11.5 | Upgrade
|
| Other Financing Activities | - | -3.8 | -11.7 | -2.9 | - | Upgrade
|
| Financing Cash Flow | -37 | -49.1 | -94.2 | 56.7 | -55.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5 | -4.1 | 0.2 | -3 | -4 | Upgrade
|
| Net Cash Flow | -17.9 | 20 | -40 | 9.2 | 7 | Upgrade
|
| Free Cash Flow | 43.1 | 82.9 | 14.6 | 71.6 | 66.3 | Upgrade
|
| Free Cash Flow Growth | -48.01% | 467.81% | -79.61% | 7.99% | - | Upgrade
|
| Free Cash Flow Margin | 6.15% | 12.05% | 2.17% | 10.47% | 11.29% | Upgrade
|
| Free Cash Flow Per Share | 0.93 | 1.80 | 0.31 | 1.51 | 1.36 | Upgrade
|
| Cash Interest Paid | 6.5 | 11.5 | 14.7 | 8.1 | 3 | Upgrade
|
| Cash Income Tax Paid | 14.1 | 3.3 | 23.6 | -2.9 | -45 | Upgrade
|
| Levered Free Cash Flow | 46.01 | 100.38 | 178.5 | -85.26 | 51.3 | Upgrade
|
| Unlevered Free Cash Flow | 50.89 | 108 | 187.88 | -79.01 | 53.36 | Upgrade
|
| Change in Working Capital | 20.2 | 35 | -18 | -24.3 | 24.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.